Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remotiv for Memory and Attention in Healthy Adults
NCT02862236Phase 4Completed
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of St. John's wort extract Ze 117 in anxiety disorder, Memory impairment, attention deficit hyperactivity disorder (ADHD). Started Feb 2017; status: completed.
02
Drugs
St. John's wort extract Ze 117
03
Conditions
anxiety disorderMemory impairmentattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02862236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862236.